← Open Payments lookup

MEGHAN LUEBBERT: Open Payments

NPI 1023644994 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$892 in 39 payments from 11 companies in 2025. Trend: 2023 $320 · 2024 $712 · 2025 $892

Food & beverage: $892
CompanyPaymentsAmount
ABBVIE INC.17$244
Collegium Pharmaceutical, Inc.6$176
Axsome Therapeutics, Inc.3$161
Vanda Pharmaceuticals Inc.5$158
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43
Janssen Pharmaceuticals, Inc1$22
E.R. Squibb & Sons, L.L.C.1$20
Tris Pharma Inc1$20
Neurocrine BioSciences, Inc.1$18
Otsuka America Pharmaceutical, Inc.1$16

Products named: VRAYLAR, Jornay PM, Auvelity, FANAPT, CAPLYTA, HETLIOZ, SPRAVATO, COBENFY.

Industry payments across NE — which companies pay providers there.